Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.40 |
| ▸ | TACR1 | P25103 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSB | P07858 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | SYK | P43405 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20122417 | 0.91 | CTRB1 (0.39) | CTRB1TACR1CTSKCTSLCTSB | |
| SCHEMBL20122488 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TACR1CTSKCTSLCTSB | |
| SCHEMBL20122430 | 0.86 | ATM (0.36) | ALDH1A1MME | |
| SCHEMBL20122429 | 0.82 | CYP1A2 (0.33) | ALDH1A1 | |
| SCHEMBL20122432 | 0.82 | KDM4E (0.31) | ALOX15 | |
| SCHEMBL20122409 | 0.82 | KDM4E (0.44) | MMEALOX15 | |
| SCHEMBL20122434 | 0.80 | — | — | |
| SCHEMBL20122529 | 0.80 | TACR1 (0.37) | CTRB1TACR1CTSKCTSLCTSB | |
| SCHEMBL20122481 | 0.80 | CTSK (0.38) | TACR1CTSKCTSLCTSBCTSS | |
| SCHEMBL20122387 | 0.80 | PPARA (0.37) | TACR1CTSKCTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963428-B1 | Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use | Nguyen, Mark Quang (US) | 2018-05-08 | — | — | US | disclosed |